Association of anticonvulsant hypersensitivity syndrome with Herpesvirus 6, 7

Epilepsy Research

Volumn 70, Issue 1, 2006, Pages 27-40

  Oskay, Tuǧba ^a   Karademir, Asli ^a   Ertürk, Özcan I ^a  

^a BAYINDIR HOSPITAL   (Turkey)

Author keywords

Anticonvulsant hypersensitivity syndrome; Herpesvirus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPIN 2 ONE DERIVATIVE; CARBAMAZEPINE; CORTICOSTEROID; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PHENOBARBITAL; PHENYTOIN; PREDNISONE; TOPIRAMATE; VIGABATRIN; VIRUS DNA;

ADOLESCENT; ADULT; ANEMIA; ANTICONVULSANT HYPERSENSITIVITY SYNDROME; ARTICLE; BRAIN; BRAIN DISEASE; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DRUG FATALITY; DRUG HYPERSENSITIVITY; EDEMA; EOSINOPHILIA; EPILEPSY; EPSTEIN BARR VIRUS; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FEMALE; FEVER; GENITAL ULCER; HEART; HEART FAILURE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HYPERAMMONEMIA; HYPOGAMMAGLOBULINEMIA; HYPOTHYROIDISM; KIDNEY; KIDNEY FAILURE; LEUKOCYTOSIS; LIVER; LIVER FAILURE; LIVER TOXICITY; LUNG; LUNG TOXICITY; LYMPHADENOPATHY; MALE; MEASLES VIRUS; MOUTH ULCER; MULTIPLE ORGAN FAILURE; MUSCLE; NEPHROTOXICITY; NONHUMAN; PANCREAS; PARVOVIRUS; POLYMERASE CHAIN REACTION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PURPURA; RASH; RUBELLA VIRUS; SEROLOGY; SKIN DEFECT; SKIN EXFOLIATION; SPLEEN; SPLENOMEGALY; THROMBOCYTOPENIA; THYROID GLAND; URTICARIA; VARICELLA ZOSTER VIRUS; VASCULITIS; VESICULAR RASH; VIROLOGY; VIRUS DETECTION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS TITRATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, VIRAL; ANTICONVULSANTS; CHILD; DNA, VIRAL; DRUG HYPERSENSITIVITY; FEMALE; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 33745421858     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.02.006     Document Type: Article

References (32)

1. Aihara M., Sugita Y., Takahashi S., et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br. J. Dermatol. 144 (2001) 1231-1234
2. Aihara Y., Ito S.I., Kobayashi Y., et al. Carbamazepine-induced hypersensitivity syndrrome associated with transient hypogammaglobulinemia and reactivation of human herpes virus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br. J. Dermatol. 149 (2003) 165-169
3. Akashi K., Eizuru Y., Sumiyoshi Y., et al. Severe infectious mononucleosis-like syndrome and primary Human Herpesvirus 6 infection in an adult. N. Engl. J. Med. 329 (1993) 168-171
4. Baba M., Karakaş M., Aksungur V.L., et al. The anticonvulsant hypersensitivity syndrome. JEADV 17 (2003) 339-401
5. Chiu S.S., Cheung C.Y., Tse C.Y.C., et al. Early diagnosis of primary Human Herpesvirus 6 in childhood: serology, polymerase chain reaction, and virus load. J. Infect. Dis. 178 (1998) 1250-1256
6. Descamps V., Bouscarat F., Laglenne S., et al. Human Herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br. J. Dermatol. 137 (1997) 605-608
7. Descamps V., Valance A., Edinger C., et al. Association of Human Herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 137 (2001) 301-304
8. Fujino Y., Nakajima M., Inoue H., et al. Human Herpesvirus 6 encephalitis associated with hypersensitivity syndrome. Ann. Neurol. 51 (2002) 771-774
9. Hamer H.M., and Morris H.H. Hypersensitivity syndrome to antiepileptic drugs. Cleve. Clin. J. Med. 66 (1999) 239-245
10. Hara H., Kobayashi M., Yokoyama A., et al. Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of Human Herpesvirus 7. Dermatology 211 (2005) 159-161
11. Hashimoto K., Yasukawa M., and Tohyama M. Human Herpesvirus 6 and drug allergy. Curr. Opin. Allergy, Clin. Immunol. 3 (2003) 255-260
12. Kaminsky A., Moreno M., Diaz M., et al. Anticonvulsant hypersensitivity syndrome. Int. J. Dermatol. 44 (2004) 594-598
13. Kano Y., Inaoka M., and Shiohara T. Association between anticonvulsant hypersensitivity syndrome and Human Herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol. 140 (2004) 183-188
14. Kano Y., and Shiohara T. Sequential reactivation of Herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm Venereol. 84 (2004) 484-485
15. Kennebeck G.A. Anticonvulsant hypersensitivity syndrome. J. Am. Board Fam. Pract. 13 (2000) 364-370
16. Le Cleach L., Fillet A.M., Agut H., and Chosidow O. Human herpes virus 6 and 7: new roles yet to be discovered. Arch. Dermatol. 134 (1998) 1155-1157
17. Mitani N., Aihara M., Yamakawa Y., et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of Human Herpesviruses. J. Med. Virol. 75 (2005) 430-434
18. Mostella J., Pieroni R., Jones R., and Finch C.K. Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin. South Med. J. 97 (2004) 319-321
19. Nagai Y., Hattori T., and Ishikawa O. A case of hypersensitivity syndrome due to phenytoin. J. Dermatol. 29 (2002) 670-673
20. Ogihara T., Takahashi T., Hanihara T., et al. Carbamazepine-induced hypersensitivity syndrome associated with Human Herpesvirus 6 reactivation. J. Clin. Psychopharmacol. 24 (2004) 105-106
21. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331 (1994) 1272-1285
22. Sanchez M.A., Perez-Garcia M., Fernandez-Jorge B., et al. Drug-induced hypersensitivity syndrome during a primary Epstein-Barr virus infection. J. Am. Acad. Dermatol. 52 (2005) 131
23. Sekine N., Motokura T., Oki T., et al. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285 (2001) 1153-1154
24. Shear N.H., and Spielberg S.P. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J. Clin. Invest. 82 (1988) 1826-1832
25. Sullivan J.R., and Shear N.H. The drug hypersensitivity syndrome: what is the pathogenesis?. Arch. Dermatol. 137 (2001) 357-364
26. Suziki Y., Inagi R., Aono T., et al. Human Herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch. Dermatol. 134 (1998) 1108-1112
27. Tas S., and Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 206 (2003) 353-356
28. Tohyama M., and Hashimoto K. Drug hypersensitivity syndrome and Human Herpesvirus 6 reactivation. Arch. Dermatol. 138 (2002) 268-269
29. Vittorio C.C., and Muglia J.J. Anticonvulsant hypersensitivity syndrome. Arch. Intern. Med. 155 (1995) 2285-2290
30. Wong G.A.E., and Shear N.H. Is a drug alone sufficient to cause the drug hypersensitivity syndrome?. Arch. Dermatol. 140 (2004) 226-229
31. Yalci{dotless}n S., Karpuzoǧlu T., Süleymanlar G., et al. Human Herpesvirus 6 and Human Herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch. Virol. 136 (1994) 183-190
32. Zeller A., Schaub N., Steffen I., et al. Drug hypersensitivity syndrome to carbamazepine and Human Herpesvirus 6 infection: case report and literature review. Infection 31 (2003) 254-256